INDIVIDUAL VARIATION IN RENAL DOSIMETRY OF Lu-177 OCTREOTATE

被引:0
|
作者
McKay, Erin [1 ]
机构
[1] St George Hosp, Sydney, NSW, Australia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:8 / 8
页数:1
相关论文
共 50 条
  • [1] Radiation Dosimetry Aspects of Lu-177
    Lassmann, Michael
    Eberlein, Uta
    CURRENT RADIOPHARMACEUTICALS, 2015, 8 (02) : 139 - 144
  • [2] Quantitative biodistribution & kinetics of a new formulation of [Lu-177]-Octreotate
    Bailey, Dale
    Hennessy, Thomas
    Willowson, Kathy
    Schembri, Geoffrey
    Roach, Paul
    Snowdon, Graeme
    Aslani, Alireza
    Pavlakis, Nick
    Clarke, Stephen
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [3] Characterisation, Measurement and Biodistribution of an Improved Formulation of [Lu-177]-Octreotate
    Bailey, D.
    Willowson, K.
    Hennessy, T.
    Schembri, G.
    Snowdon, G.
    Aslani, A.
    Roach, P.
    Pavlakis, N.
    Clarke, S.
    NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 110 - 110
  • [4] Lu-177 octreotate therapy in patients with disseminated neuroendocrine tumors. Analysis of dosimetry with impact on future strategy
    Tennvall, J.
    Garkavij, M.
    Nickel, M.
    Sjogren-Gleissner, K.
    Ljungberg, M.
    Ohlsson, T.
    Wingardh, K.
    Strand, S. E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S291 - S291
  • [5] Serial Dosimetry in Peptide Receptor Radionuclide Therapy using Lu-177 DOTATATE or Lu-177 DOTATOC in the same Patient
    Schuchardt, C.
    Kulkarni, H.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S139 - S139
  • [6] Dosimetry using Lu-177 DOTATATE, Lu-177 HA-DOTATATE and Lu-177 DOTATOC: Comparative Results in Patients Undergoing Peptide Receptor Radionuclide Therapy (PRRT)
    Schuchardt, C.
    Kulkarni, H. R.
    Wiessalla, S.
    Shahinfar, M.
    Shafaei, S.
    Kropf, S.
    Wester, H. J.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S224 - S225
  • [7] RADIATION EXPOSURES FROM LU-177 OCTREOTATE RADIOPEPTIDE THERAPY FOR NEUROENDOCRINE TUMOURS
    Calais, P.
    INTERNAL MEDICINE JOURNAL, 2012, 42 : 43 - 43
  • [8] SPECT Frame Duration Shortening: Impact on Lu-177 Dosimetry
    Winters, Celeste
    Barton, Zach
    Meyer, Catherine
    Mench, Anna
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [9] Methodological Effects in Kidney Dosimetry in Lu-177 Radionuclide Therapy
    Heikkonen, J.
    Maenpaa, H.
    Tenhunen, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S265 - S265
  • [10] The SNMMI Lu-177 Dosimetry Global Challenge: Results and Conclusions
    Dewaraja, Yuni
    Danieli, R.
    Erwin, W.
    Uribe, C.
    MEDICAL PHYSICS, 2022, 49 (06) : E450 - E451